Clinical Trials in Seoul, South Korea
Locations / Seoul, South Korea
Delta Trials hosts 13,588 clinical trials conducted in Seoul, South Korea, making it a notable site of clinical research activity. These trials covering 7,185 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 915 trials in this location have been stopped, mirroring broader trends in global research activity. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Seoul.
13588
Total Trials
7185
Conditions
915
Terminated since 2020
Browse by condition (7185 total)
- Healthy 286 trialsAll Healthy trials
- Non-small cell lung cancer 267 trialsAll Non-small cell lung cancer trials
- Breast cancer 262 trialsAll Breast cancer trials
- Coronary artery disease 232 trialsAll Coronary artery disease trials
- Gastric cancer 196 trialsAll Gastric cancer trials
- Hypertension 185 trialsAll Hypertension trials
- Diabetes mellitus, type 2 158 trialsAll Diabetes mellitus, type 2 trials
- Hepatocellular carcinoma 152 trialsAll Hepatocellular carcinoma trials
- Type 2 diabetes mellitus 118 trialsAll Type 2 diabetes mellitus trials
- Stroke 116 trialsAll Stroke trials
- Rheumatoid arthritis 114 trialsAll Rheumatoid arthritis trials
- Atrial fibrillation 108 trialsAll Atrial fibrillation trials
- Carcinoma, non-small-cell lung 105 trialsAll Carcinoma, non-small-cell lung trials
- Asthma 100 trialsAll Asthma trials
- Colorectal cancer 100 trialsAll Colorectal cancer trials
- Multiple myeloma 86 trialsAll Multiple myeloma trials
- Prostate cancer 84 trialsAll Prostate cancer trials
- Lung cancer 78 trialsAll Lung cancer trials
- Ulcerative colitis 77 trialsAll Ulcerative colitis trials
- Schizophrenia 77 trialsAll Schizophrenia trials